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Abstract
Background: The mint family (Lamiaceae) produces a wide variety of constituents with medicinal properties.
Several family members have been reported to have antiviral activity, including lemon balm (Melissa officinalis L.),
sage (Salvia spp.), peppermint (Mentha × piperita L.), hyssop (Hyssopus officinalis L.), basil (Ocimum spp.) and self-
heal (Prunella vulgaris L.). To further characterize the anti-lentiviral activities of Prunella vulgaris, water and ethanol
extracts were tested for their ability to inhibit HIV-1 infection.
Results: Aqueous extracts contained more anti-viral activity than did ethanol extracts, displaying potent antiviral
activity against HIV-1 at sub μg/mL concentrations with little to no cellular cytotoxicity at concentrations more
than 100-fold higher. Time-of-addition studies demonstrated that aqueous extracts were effective when added
during the first five hours following initiation of infection, suggesting that the botanical constituents were targeting
entry events. Further analysis revealed that extracts inhibited both virus/cell interactions and post-binding events.
While only 40% inhibition was maximally achieved in our virus/cell interaction studies, extract effectively blocked
post-binding events at concentrations similar to those that blocked infection, suggesting that it was targeting of
these latter steps that was most important for mediating inhibition of virus infectivity.
Conclusions: We demonstrate that aqueous P. vulgaris extracts inhibited HIV-1 infectivity. Our studies suggest that
inhibition occurs primarily by interference of early, post-virion binding events. The ability of aqueous extracts to
inhibit early events within the HIV life cycle suggests that these extracts, or purified constituents responsible for the
antiviral activity, are promising microbicides and/or antivirals against HIV-1.
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Background
Prunella vulgaris, commonly known as “self-heal” or
“heal-all”, is a low-growing perennial herb with world-
wide distribution. It is a member of the mint family
Lamiaceae that has been used to treat wounds, inflam-
mation, and other minor body disorders across multiple
traditional cultures [1-4].
Bioactive compounds are plentiful in both aqueous
and ethanol P. vulgaris extracts. Aqueous extracts con-
tain abundant polyphenols and complex carbohydrates,
whereas more hydrophobic metabolites, such as triter-
penes and flavonoids along with some polysaccharides
and polyphenols, are found in ethanol extracts [5-7].
Prunella vulgaris polysaccharides have pro-inflammatory
activities in a macrophage cell line [8] and immunomo-
dulatory activity in other tumor lines [9], whereas sev-
eral of its triterpenes contain significant anti-
inflammatory activity [10]. Large quantities of antioxi-
dants are known to be present in aqueous P. vulgaris
extracts with the polyphenolic compound, rosmarinic
acid, being one of the most abundant [6,11].
P. vulgaris extracts are reported to have antiviral and
anti-bacterial properties, although constituents responsi-
ble for these activities are incompletely characterized to
date [6,12,13]. Anionic polysaccharides in aqueous
extracts of P. vulgaris can decrease the replication of
herpes simplex virus-1 and -2 (HSV-1, HSV-2) by pre-
venting virus binding to cells [12,14-16].
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against the lentiviruses, HIV-1 and equine infectious ane-
mia virus (EIAV). Our earlier studies investigating the
ability of aqueous P. vulgaris extracts to inhibit EIAV
indicated that both virus binding and early post-binding
events were inhibited [17]. Previous studies have identi-
fied P. vulgaris extract inhibition of a number of steps
within the HIV life cycle including: virus binding [18],
fusion [19], reverse transcription [13], integration [20],
and protease activity [21]. While these steps of the life
cycle may be inhibited in vitro, identification of which
step(s) are inhibited during HIV infection remain poorly
elucidated. For instance, rosmarinic acid extracted from
other botanicals has proven effective against HIV-1 inte-
grase in an in vitro assay [5]; however, this polyphenol is
not responsible for the anti-retroviral activities of P. vul-
garis extracts [22-24]. Additional members of the Lamia-
ceae, such as peppermint (Mentha × piperita L.) and
lemon balm (Melissa officinalis L.), are also known to
have anti-viral activities, but specific constituents respon-
sible for those activities remain unidentified [7,14].
To date, isolation and identification of P. vulgaris com-
pounds inhibiting HIV-1 is limited to a sulfated polysac-
charide called Prunellin [5]. This constituent is likely the
same water-soluble, 10 kDa anionic constituent that was
demonstrated to interfere with HIV-1 virion binding to
permissive cells by blocking CD4 interactions [18].
In our studies, evaluation of water and ethanol
extracts from several P. vulgaris accessions demon-
strated better anti-HIV activity in aqueous extracts than
in ethanol extracts, with 50% inhibition of HIV infectiv-
ity (IC50)a ta b o u t0 . 8μg/mL of aqueous extracts. Aqu-
eous extracts from P. vulgaris Ames 27664 and 27748
were found to be about 35 times more potent against
HIV-1 infectivity than against EIAV [17]. This extract
inhibited early events in the HIV-1 life cycle. As others
have reported [18], our findings also indicated that aqu-
eous extracts blocked HIV-1 binding to permissive cells;
however, this blockage was incomplete with a maximum
of ~40% inhibition at extract concentrations that were
more than an order of magnitude higher than the IC50,
suggesting that binding interference was not primarily
responsible for the observed antiviral activity. Instead,
w ef o u n dt h a tp o s t - b i n d i n ge ntry events were strongly
inhibited with an IC50 of about 1 μg/mL, a value similar
to that found when extract was added at the initiation
of infection. Thus, we propose that inhibition of post-
binding entry events accounts for the preponderance of
the antiviral activity of P. vulgaris against HIV-1.
Materials and methods
Growth and collection of P. vulgaris accessions
All P. vulgaris plant samples were provided by the
North Central Regional Plant Introduction Station
(NCRPIS, Ames, IA) of the U.S. Department of Agricul-
ture - Agricultural Research Service. Accessions utilized
in experiments were produced in Ames, IA and grown
from seeds of populations collected in the U.S.A. and
South Ossetia, Republic of Georgia. Accession details
are provided in Table 1. Both seed and voucher speci-
mens were collected from natural populations, and spe-
cimens were keyed to species [25,26]. Seeds from
accessions were germinated in Petri plates at 25°C,
transferred to flats in a greenhouse (20-25°C) before
final field transfer into individual control pollinated
screened cages in Ames, IA. Upper flowering portions
of 14-month-old plants were harvested, dried for 1 week
at 38°C in a forced-air dryer with constant humidity and
ground for analysis. Dried samples were stored in sealed
plastic bags overlayed with nitrogen gas at -20°C until
use. All voucher specimens representing both original
and regenerated populations are stored in the Ada Hay-
den Herbarium, Iowa State University (Ames, IA: ISC).
Seeds representing both original and regenerated popu-
lations are stored at the NCRPIS under controlled con-
ditions (-20°C; 4°C for regenerated samples).
Information about the specific provenance of all acces-
sions used for the experiments is available via the Germ-
plasm Resources Information Network database at
http://www.ars-grin.gov/npgs/acc/acc_queries.html.
Extraction and fractionation of P. vulgaris
All glassware was heated at 200°C for 2 hours to destroy
endotoxin [27].
Water extraction
Boiling, endotoxin-free water was poured over dried P.
vulgaris at a ratio of 100 mL/6 g of dried tissue. The
plant material was steeped, with constant stirring, for 1
hour and filtered through a G6 glass fiber circle (Fisher
Scientific) in a Buchner funnel. The filtrate was centri-
fuged at 10,000 × g for 20 minutes to remove any addi-
tional particulates. The extract was lyophilized, weighed,
and re-dissolved in either DMSO or sterile endotoxin-
free water.
Ethanol extraction
Six g of dried P. vulgaris was extracted with 500 mL of
95% ethanol via Soxhlet for 6 hours. The extract was fil-
tered, dried by rotary evaporation at <40°C and then
lyophilized. Extracts were resuspended in DMSO.
Endotoxin levels of extracts and fractions
All extracts and fractions were evaluated for endotoxin
by using the Chromogenic Limulus Amebocyte Lysate
Test kit per manufacturer’s instructions (Cambrex
Bioscience Inc.). This assay is able to detect concentra-
tions of endotoxin of ≥0.07 EU/mL. All extracts had
<0.07 EU/mL at the highest concentrations used in
these studies.
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HeLa37 cells were maintained in high glucose DMEM
with 10% fetal calf serum (FCS). These cells ectopically
express CD4 and CCR5 and endogenously express
CXCR4 [28]. All media were supplemented with penicil-
lin and streptomycin.
Stocks of HIV-1 were generated by transient transfec-
tions of 293T cells. The molecular clones, pNL4-3 [29],
pAd8 [30] or p256 [31], were transfected into 80% con-
fluent 15 cm plates of 293T cells using either a calcium
phosphate protocol or a PEI lipofection protocol as
described [32]. Supernatants were collected at 48 hours
following transfection, filtered through a 0.45 μ filter,
distributed into 500 μL aliquots and stored at -80°C.
Viral titers were determined by infection of HeLa37
cells with the single round of infection assay as pre-
viously described [33].
Viral infection and time-of-addition studies
Inhibition of infectivity studies
Approximately 200 infectious HIV-1 particles were com-
bined with the concentrations of extracts as noted. The
amount of vehicle was adjusted so that equivalent con-
centrations of vehicle were present in all wells within an
experiment. In studies that used extracts resuspended in
DMSO, DMSO concentrations never exceeded 0.5%.
The extract and virus mixture was added to 2 × 10
4
cells/well of HeLa37 cells in a 48-well format, resulting
in a multiplicity of infection (MOI) of ~0.01. The cells
were maintained for 40 hours. Cells were fixed with 75%
acetone/25% water and immunostained for HIV anti-
gens, as previously described [33], with human anti-HIV
antisera. HIV antigen-positive cells within the infected
cell monolayer were counted and titers determined. IC50
and IC90 concentrations were determined with Table-
Curve software (Systat Academic).
To quantify the number of logs of virus infectivity
inhibited by the extract, approximately 1.15 × 10
4 infec-
tious particles of NL4-3 were incubated at room tem-
perature for 10 minutes with various concentrations of
P. vulgaris accession Ames 27748 aqueous extract. Fol-
lowing the incubation, serial dilutions of the incubated
virus were added to 2 × 10
4 HeLa37 cells in a 48-well
format and appropriate concentrations of extract on the
cells were maintained for the duration of the experi-
ment. Cells were fixed at 40 hours following infection
and immunostained as described above. Wells with
serial dilutions containing between 10 and 250 virus
positive cells were counted and back-calculations made
to obtain the numbers of infectious units of virus/mL.
Virion-stability studies
Sucrose step gradients were prepared by layering 250 μL
aliquots of decreasing concentrations of sucrose (20%-
60%) into 3 mL ultra centrifugation tubes. The gradients
were allowed to equilibrate at 4°C for 3 hours. Virions
were treated with 132 μg/mL of aqueous Ames 27664
extract or 126 μg/mL of aqueous Ames 27748 extract,
0.5% Triton-X 100 or 0.4% DMSO for 1 hour at 37°C
a n dl o a d e do n t ot h et o po ft h eg r a d i e n t s .T u b e sw e r e
centrifuged for 16 hours at 40,000 rpm in a SW60 rotor
Table 1 Provenance of P. vulgaris accessions used in this study
Accession Geographic Origin Habitat
Ames 27664 North Carolina, USA Lakeside along pine-oak forest
Ames 27665 North Carolina, USA Roadside in spruce-fir forest
Ames 27666 North Carolina, USA Trailside, rich mesic cove forest
Ames 27748 Missouri, USA Roadside along prairie remnant, partly mowed
Ames 28312 Iowa, USA Muddy, rocky bed of Rock Creek
Ames 28355 Iowa, USA Des Moines River floodplain
Ames 28356 Iowa, USA Slump below sandstone cliff
Ames 28358 Iowa, USA Cleared woods
Ames 28359 Iowa, USA Springs in dense forest
Ames 28313 Iowa, USA Mesic prairie
Ames 29161 S. Ossetia, Republic of Georgia Pine-spruce forest edge
Ames 29156 S. Ossetia, Republic of Georgia Roadside along Tana River
Ames 29160 S. Ossetia, Republic of Georgia Alpine meadow
Ames 29155 S. Ossetia, Republic of Georgia Roadside along secondary subalpine meadow
PI 656839 Iowa, USA Native prairie remnant
PI 656840 Iowa, USA Shoreline of pond
PI 656841 Iowa, USA Bottom ground field
PI 656842 Missouri, USA Roadside prairie remnant
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fifty μL aliquots were collected beginning from the top
of the tube and stored at -80°C until analyzed by
immunoblotting.
Time of addition studies
Approximately 200 infectious particles of NL4-3 were
added to wells containing 2 × 10
4 HeLa37 cells (MOI =
~0.01). Extracts of P. vulgaris Ames 27748 (10 μg/mL)
or vehicle were added to triplicate wells every hour
beginning at 2 hours prior to infection and continuing
until 8 hours after initiation of infection. Forty hours
following infection, the cells were fixed, immunostained
for HIV antigens, and the HIV-1 positive cells counted.
Extract/cell pre-incubation studies
Extract (0.1 to 50 μg/mL) was incubated in growth
media at 37°C with 2 × 10
4 cells/well of HeLa37 cells in
a 48-well format for 1 hour. At the end of the incuba-
tion, media containing the extract was removed, the
cells were washed in 1× PBS twice, and refreshed with
growth media. Approximately 250 infectious HIV-1 par-
ticles were added to the treated cells resulting in a MOI
of 0.012. Cells were fixed at 40 hours following infection
and immunostained as described above.
Extract/virion pre-incubation studies
Approximately 4 × 10
4 infectious HIV-1 particles were
combined with extracts (0.3 to 30 μg/mL) and incubated
at room temperature for 10 minutes. The mixture was
diluted 100 fold with media to reduce extract concentra-
tions to irrelevant levels and added to 2 × 10
4 cells/well
of HeLa37 cells in a 48-well format, resulting in a final
MOI of 0.02. Cells were fixed at 40 hours following
infection and immunostained as described above.
Binding studies
HIV-1 NL4-3 (3.8 × 10
5 infectious particles) was incu-
bated with 2 × 10
4 HeLa37 cells at 4°C for 1 hour (MOI
= 19) in the presence of growth media (DMEM with
10% FCS) and increasing extract concentrations. This
incubation step permitted virus/cell binding, but pre-
vented virion internalization. Unbound virus was
removed by washing the cells several times with growth
media, and washed cells were then lysed with 1% SDS.
The cell lysates were separated on a 4-20% SDS PAGE
and proteins transferred to PVDF membrane. Mem-
branes were probed for HIV capsid (rabbit antibody to
p24; #4250 NIH AIDS & Reference Reagent Program)
and HRP-conjugated mouse anti-human b-actin mono-
clonal antibody (Abcam, Cambridge, MA).
Post-binding inhibition studies
HIV-1 NL4-3 (2 × 10
5 particles) was bound to 2 × 10
4
HeLa37 cells (MOI = 10) at 4°C for 2 hour in DMEM
with 10% FCS to permit binding, but prevent virion
internalization. Media and unbound virus were removed,
and cells were refreshed with growth media containing
increasing extract concentrations and shifted to 37°C.
Forty hours following infection, the cells were fixed,
immunostained for HIV antigens, and HIV-positive cells
counted.
Cell-viability studies
Cells were plated and treated with extracts as described
above. Forty hours following treatment, cell viability was
monitored by ATPLite Assay (Packard Biosciences) per
manufacturer’s instructions.
Statistical analysis
Studies were performed at least three independent
times, except where noted in the figure legends. Means
and standard errors of the mean are shown. Student’st -
test was used to evaluate the statistical differences
between control and experimental treatments, utilizing
two-tailed distribution. A significant difference was
determined by a p-value of < 0.05 and significance is
identified in each figure. If the p-value was >0.05, the
data were not considered statistically significantly
different.
Results
Prunella vulgaris aqueous extracts inhibit HIV infectivity
without significant cell toxicity
Water and ethanol extracts were prepared from four
accessions of P. vulgaris. These extracts were screened
for their ability to inhibit virus generated from the well-
described, X4-tropic lab molecular clone of HIV-1,
pNL4-3, in a single-round infection assay in HeLa37
cells. Extracts and virus were diluted in media and
immediately incubated with cells. Forty hours following
infection, the cells were fixed, immunostained for
expression of HIV antigens, and antigen-positive cells
enumerated to determine the level of viral infection
(Figure 1A). Although both ethanol and water extracts
demonstrated some inhibition, all four water extracts
contained significantly more anti-viral activity than did
their respective ethanol counterparts. At the concentra-
tions tested, all extracts had little or no cytotoxicity.
Aqueous extracts from 14 additional accessions of P.
vulgaris from the northern hemisphere were also
assessed for anti-HIV-1 activity. All extracts abrogated
virus infection at 50 μg/mL with little cytotoxicity
(Figure 1B). At 1 to 10 μg/mL, some extracts appeared
to be somewhat more inhibitory than others, with HIV-
1 replication inhibited by 33 to 66% at 1 μg/mL of the
different extracts. As aqueous extracts of Ames 27664
a n d2 7 7 4 8d i s p l a y e ds o m eo ft h es t r o n g e s ta n t i - v i r a l
effects, these extracts were used for further study.
These aqueous extracts were evaluated for their inhibi-
tion of not only X4-tropic HIV-1, such a NL4-3, but also
for the R5-tropic strain, AD8, and the dual-tropic strain,
256 [29-31]. We found that the extracts effectively
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tions inhibiting 50% of virus infectivity (IC50 =~ 0 . 8μg/
mL) (Figure 2A). Those concentrations that inhibited 90%
of infectivity (IC90) varied somewhat from about 3 μg/mL
for NL4-3 and AD8 to 11 μg/mL for 256. No extract cyto-
toxicity was observed at concentrations as high as 100 μg/
mL, concentrations that completely abrogated virus infec-
tivity. Accurate cytotoxicity curves and the generation of
cytotoxicity concentration50 and 90 values (CC50 and
CC90) could not be obtained in these studies, since signifi-
cant killing of the monolayer was not achieved. Conse-
quently, we were unable to determine the selectivity index
(CC50/IC50)o fP. vulgaris Ames 27748 aqueous extracts;
however, our studies indicate a robust window between
the two values.
To determine the logs of reduction in particle infectiv-
ity by P. vulgaris Ames 27748 extracts, we incubated
1.15 × 10
5 infectious virions of NL4-3 with 0.03 to 30
μg/mL of aqueous extract. Virions were serially diluted
in media maintaining appropriate concentrations of
extract and added to HeLa37 cells. Virus infectivity was
evaluated 40 hours later. Incubation of virions with aqu-
eous extract reduced virion infectivity ~140-fold, an
inhibition similar to that reported for a number of clini-
cally relevant antivirals (Figure 2B) [34].
Prunella vulgaris extracts inhibit early steps in the HIV-1
life cycle
To identify the step(s) during the viral life cycle that are
inhibited by the aqueous extracts, time-of-addition
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Figure 1 Aqueous extracts of P. vulgaris inhibit HIV-1 infectivity. A) DMSO, water extracts and ethanol extracts of P. vulgaris were diluted in
media to 0.2% (water extracts: 66 μg/mL of Ames 27664, 42.2 μg/mL of Ames 27665, 59.6 μg/mL of Ames 27666, or 62.4 μg/mL of Ames 27748
and ethanol extracts: 66.8 μg/mL of Ames 27664, 69.2 μg/mL of Ames 27665, 64.2 μg/mL of Ames 27666, or 67.4 μg/mL of Ames 27748).
Equivalent numbers of HIV-1 NL4-3 virions were added to each well of HeLa37 cells along with the diluted extracts. Forty hours following
infection, cells were fixed and immunostained for viral antigens. Cell-viability studies were performed in parallel in uninfected HeLa37 cells and
are shown by the hatched line. Cell viability and virus infectivity are shown as a ratio of the values in the presence of the extracts divided by the
DMSO control. Shown are the averages and standard errors of three experiments performed in triplicate. B) The anti-HIV-1 dose response curve
of 14 aqueous extracts of P. vulgaris accessions collected from the U.S. and the Republic of Georgia. All plant material was grown at NCRPIS,
Ames, IA. Concentrations of the aqueous extracts noted were mixed with equivalent numbers of NL4-3 virions and added to HeLa37 cells as
described in A. Cytotoxicity of the extracts are shown in parallel as the black line. Data are represented as the means and standard errors of the
mean of two experiments performed in triplicate.
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Page 5 of 10experiments were performed. HeLa37 cells were infected
with NL4-3 at time zero. At times noted in Figure 3, a
final concentration of 10 μg/mL of aqueous P. vulgaris
extract was added to each well, and the infection contin-
ued for a total of 40 hours. Addition of extracts at the
initiation of infection resulted in >95% inhibition of
HIV-1 infection. Adding the extract one hour following
initiation of infection reduced the inhibitory activity of
the extract slightly to 87% inhibition and by 4 hours the
extract was <50% as effective as when it was added at
the initiation of infection (Figure 3). Studies have shown
that reverse transcription of the HIV-1 genome is
initiated at ~5 hours following infection and requires
several further hours for complete genomic DNA synth-
esis [35,36]. Thus, the extract must be inhibiting one or
more steps of the HIV-1 life cycle prior to reverse
transcription.
To further dissect the mechanism of aqueous P. vul-
garis extract inhibition, we assessed whether the extracts
were altering the integrity of viral particles, thereby ren-
dering them non-infectious. Previous studies with
extracts from other Lamiaceae species demonstrated
that botanical constituents alter the density of virions,
suggesting that components of the extract were binding
to the virus particles and perhaps inactivating them [7].
HIV-1 NL4-3 was incubated with a final concentration
of 132 μg/mL of aqueous extract of Ames 27664 or 126
μg/mL of Ames 27748 extract for one hour at 37°C. As
a control, 0.5% Triton X-100 was added to virions to
lyse the viral particles. Samples were separated on a dis-
continuous sucrose gradient by ultracentrifugation. Frac-
tions were collected and analyzed for HIV-1 capsid p24
by immunoblotting, thereby assessing the location of a
virion-associated HIV protein within the sucrose gradi-
ent. Capsid protein was present primarily in fractions 5-
7 of untreated samples, whereas Triton X-100 shifted
capsid nearer the top of the gradient, indicating lysis of
the virions (Figure 4). The location of capsid remained
in fractions 6 and 7 in the presence of high concentra-
tions of either extract, demonstrating that virions
remain intact in the presence of the extract. This finding
also suggested that the extracts were not heavily coating
the virions, thereby altering their density.
We performed three different assays to determine if
P. vulgaris aqueous extracts altered virion/cell interac-
tions. In our first set of studies, extracts were pre-incu-
bated for 1 hour at 37°C with HeLa37 cells. Unbound
extract was removed, media was refreshed, virus was
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Figure 2 Aqueous P. vulgaris extracts inhibit both X4 and R5
HIV-1. A) Dose response curves of extract inhibition of X4 virus
NL4-3 (squares), R5 virus AD8 (triangles) and dual tropic 256 virus
(circles). Cytotoxicity of extract was performed in parallel in
uninfected cells (open squares). Infections were maintained for forty
hours. Cells were fixed and immunostained for HIV antigens and
number of HIV antigen-positive cells enumerated. Data are
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extract added. Shown are the averages and standard errors of three
experiments performed in triplicate. B) Log-log plot of HIV-1 NL4-3
replication in the presence of aqueous P. vulgaris extract. Extract
was incubated with 1.15 × 10
5 infectious virions and the mixture
serially diluted in media containing appropriate amounts of extract
and added to HeLa37 cells. Infected cells were maintained for 40
hours, fixed and immunostained for HIV antigens as described in A.
Shown are the averages and standard errors of three experiments
performed in triplicate.
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Figure 3 Time-of-addition studies. HIV-1 NL4-3 virions (MOI =
0.01) were added to HeLa37 cells at time zero. A final concentration
of 10 μg/mL of P. vulgaris Ames 27748 extract was added to the
cultures at times noted and extract was maintained on the cells for
the remainder of the infection. Cells were fixed and immunostained
for viral antigens at 40 hours following initiation of the experiment.
Data are represented as the percent of control wells (Con) that did
not have extract added. Each experiment was performed in
triplicate and independently performed three times. Shown are the
mean and standard error of the mean for each time point.
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Page 6 of 10added to the treated cells, and infections were assessed at
40 hours following initiation. Extract/cell pre-incubation
had a small, but statistically significant inhibition of HIV
infectivity, decreasing infection by about 20% at 10 to 100
μg/mL of extract (Figure 5A). We also assessed if the pre-
incubation of extracts with virions affected virus infectiv-
ity. When virus was pre-incubated with extract and the
mixture was diluted with media 100 fold to achieve irrele-
vant concentrations of extract prior to addition to cells,
partial inhibition of infectivity was achieved with as little
as 1 μg/mL and as high as 30 μg/mL, providing evidence
that extract and virions interact and this interaction pro-
vides partial inhibition of infectivity (Figure 5B). We also
directly evaluated if the extract interfered with HIV bind-
ing to permissive cells. HIV-1 NL4-3 (MOI = 2) was incu-
bated with HeLa37 cells at 4°C for 2 hours in the presence
of increasing concentrations of aqueous extract from P.
vulgaris Ames 27748. Unbound viruses were removed
with several washes, and cells were lysed. Cell lysates were
Figure 4 Density of HIV-1 is not altered by aqueous P. vulgaris
extract. HIV NL4-3 virions were untreated or treated with 0.5% Triton
X-100, 132 μg/mL of aqueous extracts of Ames 27664 or 126 μg/mL
of Ames 27748 for 1 hour at 37°C. Virus was applied to the top of a
20-60% sucrose gradient and ultracentrifuged. Fractions were
collected, separated on SDS PAGE and transferred to nitrocellulose.
The blot was probed with an antibody against HIV-1 p24.
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Figure 5 P. vulgaris extracts have a modest effect on HIV-1 binding to permissive cells. A) Pre-incubation of extract with cells. HeLa37
cells were pre-incubated with concentrations of aqueous extracts noted in the panel in DMEM with 10% FCS for 1 hour at 37°C. Unbound
extracts were removed and cells were suspended in fresh media and 200 infectious units of HIV-1 NL4-3 added to the culture (MOI = 0.01). Cells
were fixed and immunostained for HIV antigens 40 hours after infection. Pre-exposure of cells to extract reduced the level of virus infectivity by
20%, which was statistically significantly different from the control. *, p < 0.05. B) Pre-incubation of extracts with virions. Approximately 4 × 10
4
infectious HIV-1 NL4-3 particles were combined with extracts and incubated at room temperature for 10 minutes. The mixture was diluted 100
fold with media to reduce extract concentrations to irrelevant levels and added to 2 × 10
4 cells/well of HeLa37 cells in a 48-well format,
resulting in a final MOI of 0.02. Cells were fixed at 40 hours following infection and immunostained as described above. **, p < 0.01; ***, p <
0.001. C) Ability of extracts to inhibit HIV-1 binding to cells. Increasing concentrations of P. vulgaris extract were incubated with HIV-1 NL4-3 (3.8
×1 0
5 infectious particles) (MOI = 19) and 2 × 10
4 HeLa37 cells at 4°C for 2 hours in DMEM with 10% FCS. Unbound virus was removed with
several washes of media and cells were then lysed. Cell lysates were immunoblotted for HIV-1 p24 and cellular b-actin. All experiments were
performed in triplicate and independently performed three times.
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Blots were probed for both capsid p24 and b-actin. The
presence of 10 μg/mL of extract modestly decreased virus
binding to cells, consistent with the decrease in infectivity
shown in Figure 5A and 5B (Figure 5C). In total these
findings support the possibility that extract blocks HIV
binding to cells as others have reported [5,18]. However,
inhibition was incomplete even at extract concentrations
that were significantly higher than those required to inhi-
bit virus infectivity, suggesting that other steps within the
virus life cycle are also inhibited by compounds in the
extract.
To determine if entry events that are downstream from
virus binding were inhibited by the extract, NL4-3 was
incubated with HeLa37 cells at 4°C for 2 hours to allow
virus binding, but prevent internalization. Unbound virus
was washed away, prewarmed media containing increasing
concentrations of extract were added to the cells, and the
cells were then shifted to 37°C for the remainder of the
experiment. In these experiments, the extract effectively
inhibited HIV infectivity with a similar dose response
curve and at a similar IC50 concentration to that found
when extract was added at the initiation of infection (Fig-
ure 6). These findings supported the possibility that post-
binding events are inhibited by the extract and that this
inhibition is likely to be primarily responsible for the inhi-
bition of HIV-1 infectivity by the P. vulgaris extract.
Discussion
This study explored the antiviral activity of P. vulgaris
extracts against HIV-1. Aqueous extracts from several
accessions demonstrated more robust antiviral activity
than did their ethanol counterparts, indicating that polar
constituents are important for the antiviral activity.
These findings are consistent with previous antiviral
observations made with P. vulgaris extracts in studies
against EIAV and HSV [12,14,16,17]. Time-of-addition
studies demonstrated that early events within the life
cycle of HIV-1 were inhibited. The extracts reduced virus
infectivity by more than two logs and inhibited both R5-
and X4-tropic viruses, suggesting that inhibition was not
occurring through interference with specific virion inter-
actions with one of the host’sc h e m o k i n er e c e p t o r s .T h e
extracts were found to inhibit viral entry through at least
two different mechanisms. Extracts interfered with HIV-
1 virion binding to permissive cells when pre-incubated
with either virions or target cells; however, this inhibition
was incomplete, maximally producing about 40% inhibi-
tion. Consistent with the relatively modest effect that the
extract had in these experiments, HIV-1 binding to cells
was only partially inhibited by high concentrations (10
μg/mL or more) of extract. In contrast, the addition of
extract following pre-binding of HIV-1 to cells was
almost as effective at blocking virus infection as the addi-
tion of the extract at the time of infection. While we can-
not exclude the possibility that the addition of extract is
removing pre-bound viruses from the surface cells, our
overall findings suggest that the extract principally inhi-
bits HIV-1 infectivity by blocking one or more post-bind-
ing entry steps. An earlier study reported that aqueous P.
vulgaris extracts interferes with six-helix bundle forma-
tion [19]. Our findings are consistent with these observa-
tions, suggesting that inhibition of virus fusion events
may principally be responsible for the inhibition of HIV
infectivity by P. vulgaris.
Interestingly, our studies with aqueous P. vulgaris
extracts indicate that this extract has significantly stron-
ger inhibitory activity against HIV-1 than against the
related lentivirus EIAV, with HIV-1 inhibition observed
with sub-μg/mL concentrations of extracts. Using
extracts from the same P. vulgaris accessions (Ames
27664 and 27748), EIAV inhibition occurred with an
IC50 of ~28 μg / m L[ 1 7 ] .A sw i t hH I V - 1 ,a q u e o u s
extracts inhibited EIAV infection by blocking virus
entry, impacting both binding and post-adherence
events. Extract fractionation and identification of the
bioactive constituents will be required to determine if a
single compound, a related group of compounds or
multiple, disparate ones are responsible for the anti-len-
tiviral effects and whether it is the same or different
constituents responsible for inhibiting EIAV and HIV-1.
Identification and purification of the bioactive com-
pounds that are present in the aqueous extracts of P.
vulgaris is ongoing. Preliminary fractionation studies
indicated that constituents with quite different solubility
properties in ethanol have significant anti-HIV-1
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Figure 6 Aqueous P. vulgaris extracts inhibit early post-binding
events in the HIV-1 life cycle. HIV-1 NL4-3 was bound to HeLa37
cells for 2 hours at 4°C. Unbound virus was removed and the cells
were refreshed with warmed media containing noted amounts of
aqueous extract. Infections were maintained for an additional 40
hours, fixed and immunostained for HIV antigens. Data are
represented as the percent of control wells that did not have
extract added. Shown are the mean and standard error of the mean
for each time point and studies were performed in triplicate three
independent times.
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Page 8 of 10activity, suggesting that multiple antiviral compounds
are present in the extract (data not shown). Our studies
suggest that both large carbohydrates and tannins may
contribute to the anti-HIV-1 activity. To date, a single
anti-HIV constituent from P. vulgaris has been identi-
fied. This is a10 kDa sulfated carbohydrate called Pru-
nellin that inhibits HIV entry [5]. Interestingly, a
carbohydrate of approximately that same size was
responsible for inhibiting HSV-1 entry into cells [16].
Prunellin may be responsible for the P. vulgaris inhibi-
tion of binding of these enveloped viruses to cells.
Whether it is Prunellin or if other unidentified P. vul-
garis constituents are responsible for the inhibition of
post-binding entry events remains to be determined.
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HIV: human immunodeficiency virus; EIAV: equine infectious anemia virus;
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